Short-Term Antithyroid Drug Therapy
- 28 July 1977
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 297 (4) , 212-213
- https://doi.org/10.1056/nejm197707282970410
Abstract
During the past three decades many physicians have treated thyrotoxic patients with antithyroid drugs until toxicosis was controlled, and then discontinued therapy. Thyroid "experts" have usually counseled that this was an erroneous approach, and that therapy should be continued for one year or longer. Belief in the need for a prolonged period of therapy was based on evidence that treatment for an additional one or two years seemed to produce a higher proportion of remission,1 but it must be agreed that there is scanty critical evaluation of just how long a course of therapy is actually needed. Now, as is . . .Keywords
This publication has 6 references indexed in Scilit:
- Biosynthesis of thyroid hormone: Basic and clinical aspectsMetabolism, 1977
- THE IN VITRO SUPPRESSION OF LECTIN INDUCED3H-THYMIDINE INCORPORATION INTO DNA OF PERIPHERAL BLOOD LYMPHOCYTES AFTER THE ADDITION OF PROPYLTHIOURACIL.Journal of Clinical Endocrinology & Metabolism, 1976
- HORMONAL PATTERN OF RELAPSE IN HYPERTHYROIDISMThe Lancet, 1975
- Effects of Antithyroid Therapy on the Long-Acting Thyroid Stimulator and the Antithyroglobulin Antibodies1Journal of Clinical Endocrinology & Metabolism, 1969
- THYROIDAL SUPPRESSION BY TRIIODOTHYRONINE AS A GUIDE TO DURATION OF TREATMENT OF THYROTOXICOSIS WITH ANTITHYROID DRUGSThe Lancet, 1966
- MEDICAL THERAPY OF THYROTOXICOSIS IN CHILDRENPediatrics, 1962